Cytokinetics sec filings
WebMay 16, 2024 · EX-99.1 CYTOKINETICS AND ROYALTY PHARMA ANNOUNCE $100 MILLION TRANSACTION FOR OMECAMTIV MECARBIL Royalty Pharma Buys 4.5 … WebThis will confirm the agreement by and among the undersigned that the Schedule 13G filed with the Securities and Exchange Commission on or about the date hereof with respect to the beneficial ownership by the undersigned of the Common Stock, par value $0.001 per share, of Cytokinetics, Incorporated, a Delaware corporation, will be filed on behalf of …
Cytokinetics sec filings
Did you know?
WebApr 9, 2024 · Posted by Defense World Staff on Apr 9th, 2024 Inspire Investing LLC increased its stake in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK – Get Rating) by 19.1% during the 4th quarter,... WebApr 10, 2024 · Cytokinetics assumes no obligation to update its forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release.
WebMar 27, 2024 · empowering muscle empowering lives. Cytokinetics is committed to our mission of developing potential medicines that may improve the healthspan of people living with cardiovascular and … WebMar 27, 2024 · INVESTORS & MEDIA SEC FILINGS SEC Filing Keyword Search Group Filing year Items per page 10 1 2 3 4 5 6 7 8 9 … Next › Last » Displaying 1 - 10 of 1876 results Mar 07 2024 10:35 am EST Data Provided by Refinitiv. Minimum 15 minutes delayed. STOCK CHART
WebFind the latest SEC Filings data for Cytokinetics, Incorporated Common Stock (CYTK) at Nasdaq.com. Cytokinetics, Incorporated Common Stock (CYTK) SEC Filings … WebSep 30, 2024 · Pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2024 Cytokinetics, …
WebMar 15, 2024 · Wed., March 15, 2024 MarketBeat Advisory Research Inc. lowered its holdings in Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 32.7% during the third quarter, according to its most recent filing with the …
WebJul 1, 2024 · Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in … floral arrangement with mini pomsWebMar 3, 2024 · Fri., March 3, 2024 MarketBeat Logos Global Management LP cut its holdings in shares of Cytokinetics, Incorporated ( NASDAQ:CYTK - Get Rating) by 2.9% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). floral arranging classes sandston vaWebCytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. floral arranging classes mnWebApr 8, 2024 · Cytokinetics Inc (CYTK) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, May 10, 2024. Home. SEC Filings. ... Screenshots of actual 10-K and 10-Q SEC Filings in PDF, Word and Excel formats. Last10K.com Member Feature. Export Annual and Quarterly Reports to Adobe Acrobat (PDF), Microsoft Word (DOCX), … floral arranging classes richmond vaWebCytokinetics Inc. SEC filings breakout by MarketWatch. View the CYTK U.S. Securities and Exchange Commission reporting information. great salt lake swimming beachWebMar 13, 2024 · Thornburg Investment Management Inc. acquired a new stake in shares of Cytokinetics, Incorporated (NASDAQ:CYTK - Get Rating) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 74,198 shares of the biop great salt lake the flooding desertWebApr 12, 2024 · The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. In related news, CEO Robert I. Blum sold 12,500 shares of the stock in a transaction that ... floral arranging certificate